U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07170748) titled 'Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)' on Sept. 05.
Brief Summary: Performance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human Immunodeficiency Virus (HIV), Hepatitis B and C and Syphilis) from serum, plasma samples collected prospectively or retrospectively in Ivory Coast and Kenya.
Study Start Date: Oct., 2025
Study Type: OBSERVATIONAL
Condition:
Multiplex Testing of HIV, HBV, HCV and Syphilis
HIV
HBV
HCV
Syphilis
Point of Care Testing
Recruitment Status: RECRU...